Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Free Cash Flow Generation Index

Latest as of December 2025: 0.68x

Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of CN¥15.33 Million represents 1% of operating cash flow (CN¥22.41 Million). See 688193 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.68x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥15.33 Million
CNY

Operating Cash Flow

CN¥22.41 Million
CNY

Capital Expenditures

CN¥7.07 Million
CNY

Shanghai Rendu Biotechnology Co. Ltd. A Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Explore 688193 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)

Year-by-year Free Cash Flow Generation Index for Shanghai Rendu Biotechnology Co. Ltd. A. For the full company profile including market capitalisation, see 688193 market cap.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.68x CN¥15.33 Million CN¥22.41 Million CN¥7.07 Million ▲ +20.4%
2024 0.57x CN¥13.86 Million CN¥24.39 Million CN¥10.52 Million ▲ +405.6%
2023 -0.19x CN¥-3.20 Million CN¥17.19 Million CN¥20.39 Million ▼ -136.2%
2021 0.51x CN¥27.97 Million CN¥54.44 Million CN¥26.48 Million ▼ -38.3%
2020 0.83x CN¥77.06 Million CN¥92.61 Million CN¥15.55 Million ▲ +127.6%
2019 -3.01x CN¥-41.16 Million CN¥13.67 Million CN¥54.83 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).